Molina Healthcare, Inc. (NYSE:MOH - Get Free Report) has been given an average rating of "Hold" by the fifteen ratings firms that are covering the company, Marketbeat reports. Nine research analysts have rated the stock with a hold recommendation and six have issued a buy recommendation on the company. The average 12-month target price among analysts that have covered the stock in the last year is $365.38.
A number of research analysts recently commented on the stock. StockNews.com raised shares of Molina Healthcare from a "hold" rating to a "buy" rating in a research report on Friday, April 11th. Stephens reaffirmed an "equal weight" rating and set a $345.00 price objective on shares of Molina Healthcare in a report on Thursday, February 6th. Robert W. Baird reissued a "neutral" rating and issued a $375.00 target price (up from $331.00) on shares of Molina Healthcare in a report on Tuesday, April 15th. UBS Group dropped their price target on Molina Healthcare from $374.00 to $325.00 and set a "neutral" rating on the stock in a research note on Friday, February 7th. Finally, Baird R W lowered Molina Healthcare from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, April 15th.
Read Our Latest Stock Report on Molina Healthcare
Insiders Place Their Bets
In other Molina Healthcare news, CEO Joseph M. Zubretsky sold 87,500 shares of the company's stock in a transaction on Wednesday, April 30th. The stock was sold at an average price of $320.06, for a total value of $28,005,250.00. Following the sale, the chief executive officer now owns 257,715 shares of the company's stock, valued at approximately $82,484,262.90. This represents a 25.35 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Steven J. Orlando sold 1,000 shares of the firm's stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $301.33, for a total transaction of $301,330.00. Following the transaction, the director now owns 17,375 shares of the company's stock, valued at $5,235,608.75. This trade represents a 5.44 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 89,169 shares of company stock worth $28,520,995. 1.10% of the stock is owned by company insiders.
Institutional Trading of Molina Healthcare
Several large investors have recently modified their holdings of the business. Rothschild Investment LLC grew its holdings in Molina Healthcare by 126.3% during the 1st quarter. Rothschild Investment LLC now owns 86 shares of the company's stock valued at $28,000 after buying an additional 48 shares during the last quarter. Deseret Mutual Benefit Administrators increased its position in Molina Healthcare by 60.7% during the 1st quarter. Deseret Mutual Benefit Administrators now owns 90 shares of the company's stock worth $30,000 after purchasing an additional 34 shares in the last quarter. Colonial Trust Co SC increased its position in Molina Healthcare by 930.0% during the 4th quarter. Colonial Trust Co SC now owns 103 shares of the company's stock worth $30,000 after purchasing an additional 93 shares in the last quarter. Silver Oak Securities Incorporated acquired a new position in Molina Healthcare in the 1st quarter valued at about $34,000. Finally, Versant Capital Management Inc lifted its holdings in Molina Healthcare by 83.1% in the 4th quarter. Versant Capital Management Inc now owns 163 shares of the company's stock valued at $47,000 after purchasing an additional 74 shares in the last quarter. 98.50% of the stock is currently owned by institutional investors and hedge funds.
Molina Healthcare Stock Up 0.5 %
NYSE:MOH traded up $1.57 during trading hours on Wednesday, hitting $319.61. The company's stock had a trading volume of 460,292 shares, compared to its average volume of 678,006. The stock has a market capitalization of $17.32 billion, a P/E ratio of 15.64, a price-to-earnings-growth ratio of 1.06 and a beta of 0.70. The company has a current ratio of 1.62, a quick ratio of 1.62 and a debt-to-equity ratio of 0.69. The stock has a fifty day moving average of $322.95 and a 200-day moving average of $307.51. Molina Healthcare has a 52-week low of $262.32 and a 52-week high of $365.23.
Molina Healthcare (NYSE:MOH - Get Free Report) last issued its earnings results on Wednesday, April 23rd. The company reported $6.08 earnings per share for the quarter, topping the consensus estimate of $5.96 by $0.12. The business had revenue of $11.15 billion for the quarter, compared to analyst estimates of $10.86 billion. Molina Healthcare had a return on equity of 28.13% and a net margin of 2.90%. The business's quarterly revenue was up 12.2% on a year-over-year basis. During the same quarter last year, the company earned $5.73 EPS. On average, equities analysts forecast that Molina Healthcare will post 24.4 earnings per share for the current year.
Molina Healthcare Company Profile
(
Get Free ReportMolina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.
Featured Stories

Before you consider Molina Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Molina Healthcare wasn't on the list.
While Molina Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.